Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

Clinical trial NCT07224763 · RECRUITING

Trial details

NCT number: NCT07224763
Sponsor: United Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ESRD (End-Stage Renal Disease)Kidney Transplantation Xenotransplantation

Start date: 2026-06-01
Primary completion: 2029-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.